Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,628
archived clinical trials in
Schizophrenia

A Long-Term, Open-Label, Study on Schizophrenia
A Long-Term, Open-Label, Multicenter Study of LY2140023 Compared to Atypical Antipsychotic Standard of Care in Patients With DSM-IV-TR Schizophrenia
Status: Enrolling
Updated:  9/7/2012
Clinical Research Facility
mi
from
Fayetteville, AR
A Long-Term, Open-Label, Study on Schizophrenia
A Long-Term, Open-Label, Multicenter Study of LY2140023 Compared to Atypical Antipsychotic Standard of Care in Patients With DSM-IV-TR Schizophrenia
Status: Enrolling
Updated: 9/7/2012
Clinical Research Facility
mi
from
Fayetteville, AR
Click here to add this to my saved trials
A Long-Term, Open-Label, Study on Schizophrenia
A Long-Term, Open-Label, Multicenter Study of LY2140023 Compared to Atypical Antipsychotic Standard of Care in Patients With DSM-IV-TR Schizophrenia
Status: Enrolling
Updated:  9/7/2012
Clinical Research Facility
mi
from
Los Angeles, CA
A Long-Term, Open-Label, Study on Schizophrenia
A Long-Term, Open-Label, Multicenter Study of LY2140023 Compared to Atypical Antipsychotic Standard of Care in Patients With DSM-IV-TR Schizophrenia
Status: Enrolling
Updated: 9/7/2012
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Long-Term, Open-Label, Study on Schizophrenia
A Long-Term, Open-Label, Multicenter Study of LY2140023 Compared to Atypical Antipsychotic Standard of Care in Patients With DSM-IV-TR Schizophrenia
Status: Enrolling
Updated:  9/7/2012
Clinical Research Facility
mi
from
Washington,
A Long-Term, Open-Label, Study on Schizophrenia
A Long-Term, Open-Label, Multicenter Study of LY2140023 Compared to Atypical Antipsychotic Standard of Care in Patients With DSM-IV-TR Schizophrenia
Status: Enrolling
Updated: 9/7/2012
Clinical Research Facility
mi
from
Washington,
Click here to add this to my saved trials
A Long-Term, Open-Label, Study on Schizophrenia
A Long-Term, Open-Label, Multicenter Study of LY2140023 Compared to Atypical Antipsychotic Standard of Care in Patients With DSM-IV-TR Schizophrenia
Status: Enrolling
Updated:  9/7/2012
Clinical Research Facility
mi
from
Miami, FL
A Long-Term, Open-Label, Study on Schizophrenia
A Long-Term, Open-Label, Multicenter Study of LY2140023 Compared to Atypical Antipsychotic Standard of Care in Patients With DSM-IV-TR Schizophrenia
Status: Enrolling
Updated: 9/7/2012
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Long-Term, Open-Label, Study on Schizophrenia
A Long-Term, Open-Label, Multicenter Study of LY2140023 Compared to Atypical Antipsychotic Standard of Care in Patients With DSM-IV-TR Schizophrenia
Status: Enrolling
Updated:  9/7/2012
Clinical Research Facility
mi
from
Athens, GA
A Long-Term, Open-Label, Study on Schizophrenia
A Long-Term, Open-Label, Multicenter Study of LY2140023 Compared to Atypical Antipsychotic Standard of Care in Patients With DSM-IV-TR Schizophrenia
Status: Enrolling
Updated: 9/7/2012
Clinical Research Facility
mi
from
Athens, GA
Click here to add this to my saved trials
A Long-Term, Open-Label, Study on Schizophrenia
A Long-Term, Open-Label, Multicenter Study of LY2140023 Compared to Atypical Antipsychotic Standard of Care in Patients With DSM-IV-TR Schizophrenia
Status: Enrolling
Updated:  9/7/2012
Clinical Research Facility
mi
from
Chicago, IL
A Long-Term, Open-Label, Study on Schizophrenia
A Long-Term, Open-Label, Multicenter Study of LY2140023 Compared to Atypical Antipsychotic Standard of Care in Patients With DSM-IV-TR Schizophrenia
Status: Enrolling
Updated: 9/7/2012
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
A Long-Term, Open-Label, Study on Schizophrenia
A Long-Term, Open-Label, Multicenter Study of LY2140023 Compared to Atypical Antipsychotic Standard of Care in Patients With DSM-IV-TR Schizophrenia
Status: Enrolling
Updated:  9/7/2012
Clinical Research Facility
mi
from
Indianapolis, IN
A Long-Term, Open-Label, Study on Schizophrenia
A Long-Term, Open-Label, Multicenter Study of LY2140023 Compared to Atypical Antipsychotic Standard of Care in Patients With DSM-IV-TR Schizophrenia
Status: Enrolling
Updated: 9/7/2012
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Long-Term, Open-Label, Study on Schizophrenia
A Long-Term, Open-Label, Multicenter Study of LY2140023 Compared to Atypical Antipsychotic Standard of Care in Patients With DSM-IV-TR Schizophrenia
Status: Enrolling
Updated:  9/7/2012
Clinical Research Facility
mi
from
Topeka, KA
A Long-Term, Open-Label, Study on Schizophrenia
A Long-Term, Open-Label, Multicenter Study of LY2140023 Compared to Atypical Antipsychotic Standard of Care in Patients With DSM-IV-TR Schizophrenia
Status: Enrolling
Updated: 9/7/2012
Clinical Research Facility
mi
from
Topeka, KA
Click here to add this to my saved trials
A Long-Term, Open-Label, Study on Schizophrenia
A Long-Term, Open-Label, Multicenter Study of LY2140023 Compared to Atypical Antipsychotic Standard of Care in Patients With DSM-IV-TR Schizophrenia
Status: Enrolling
Updated:  9/7/2012
Clinical Research Facility
mi
from
Alexandria, LA
A Long-Term, Open-Label, Study on Schizophrenia
A Long-Term, Open-Label, Multicenter Study of LY2140023 Compared to Atypical Antipsychotic Standard of Care in Patients With DSM-IV-TR Schizophrenia
Status: Enrolling
Updated: 9/7/2012
Clinical Research Facility
mi
from
Alexandria, LA
Click here to add this to my saved trials
A Long-Term, Open-Label, Study on Schizophrenia
A Long-Term, Open-Label, Multicenter Study of LY2140023 Compared to Atypical Antipsychotic Standard of Care in Patients With DSM-IV-TR Schizophrenia
Status: Enrolling
Updated:  9/7/2012
Clinical Research Facility
mi
from
Picayune, MS
A Long-Term, Open-Label, Study on Schizophrenia
A Long-Term, Open-Label, Multicenter Study of LY2140023 Compared to Atypical Antipsychotic Standard of Care in Patients With DSM-IV-TR Schizophrenia
Status: Enrolling
Updated: 9/7/2012
Clinical Research Facility
mi
from
Picayune, MS
Click here to add this to my saved trials
A Long-Term, Open-Label, Study on Schizophrenia
A Long-Term, Open-Label, Multicenter Study of LY2140023 Compared to Atypical Antipsychotic Standard of Care in Patients With DSM-IV-TR Schizophrenia
Status: Enrolling
Updated:  9/7/2012
Clinical Research Facility
mi
from
Kansas City, MO
A Long-Term, Open-Label, Study on Schizophrenia
A Long-Term, Open-Label, Multicenter Study of LY2140023 Compared to Atypical Antipsychotic Standard of Care in Patients With DSM-IV-TR Schizophrenia
Status: Enrolling
Updated: 9/7/2012
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
A Long-Term, Open-Label, Study on Schizophrenia
A Long-Term, Open-Label, Multicenter Study of LY2140023 Compared to Atypical Antipsychotic Standard of Care in Patients With DSM-IV-TR Schizophrenia
Status: Enrolling
Updated:  9/7/2012
Clinical Research Facility
mi
from
Bridgewater, NJ
A Long-Term, Open-Label, Study on Schizophrenia
A Long-Term, Open-Label, Multicenter Study of LY2140023 Compared to Atypical Antipsychotic Standard of Care in Patients With DSM-IV-TR Schizophrenia
Status: Enrolling
Updated: 9/7/2012
Clinical Research Facility
mi
from
Bridgewater, NJ
Click here to add this to my saved trials
A Long-Term, Open-Label, Study on Schizophrenia
A Long-Term, Open-Label, Multicenter Study of LY2140023 Compared to Atypical Antipsychotic Standard of Care in Patients With DSM-IV-TR Schizophrenia
Status: Enrolling
Updated:  9/7/2012
Clinical Research Facility
mi
from
Brooklyn, NY
A Long-Term, Open-Label, Study on Schizophrenia
A Long-Term, Open-Label, Multicenter Study of LY2140023 Compared to Atypical Antipsychotic Standard of Care in Patients With DSM-IV-TR Schizophrenia
Status: Enrolling
Updated: 9/7/2012
Clinical Research Facility
mi
from
Brooklyn, NY
Click here to add this to my saved trials
A Long-Term, Open-Label, Study on Schizophrenia
A Long-Term, Open-Label, Multicenter Study of LY2140023 Compared to Atypical Antipsychotic Standard of Care in Patients With DSM-IV-TR Schizophrenia
Status: Enrolling
Updated:  9/7/2012
Clinical Research Facility
mi
from
Cincinnati, OH
A Long-Term, Open-Label, Study on Schizophrenia
A Long-Term, Open-Label, Multicenter Study of LY2140023 Compared to Atypical Antipsychotic Standard of Care in Patients With DSM-IV-TR Schizophrenia
Status: Enrolling
Updated: 9/7/2012
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Long-Term, Open-Label, Study on Schizophrenia
A Long-Term, Open-Label, Multicenter Study of LY2140023 Compared to Atypical Antipsychotic Standard of Care in Patients With DSM-IV-TR Schizophrenia
Status: Enrolling
Updated:  9/7/2012
Clinical Research Facility
mi
from
Philadelphia, PA
A Long-Term, Open-Label, Study on Schizophrenia
A Long-Term, Open-Label, Multicenter Study of LY2140023 Compared to Atypical Antipsychotic Standard of Care in Patients With DSM-IV-TR Schizophrenia
Status: Enrolling
Updated: 9/7/2012
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Long-Term, Open-Label, Study on Schizophrenia
A Long-Term, Open-Label, Multicenter Study of LY2140023 Compared to Atypical Antipsychotic Standard of Care in Patients With DSM-IV-TR Schizophrenia
Status: Enrolling
Updated:  9/7/2012
Clinical Research Facility
mi
from
Fort Worth, TX
A Long-Term, Open-Label, Study on Schizophrenia
A Long-Term, Open-Label, Multicenter Study of LY2140023 Compared to Atypical Antipsychotic Standard of Care in Patients With DSM-IV-TR Schizophrenia
Status: Enrolling
Updated: 9/7/2012
Clinical Research Facility
mi
from
Fort Worth, TX
Click here to add this to my saved trials
A Long-Term, Open-Label, Study on Schizophrenia
A Long-Term, Open-Label, Multicenter Study of LY2140023 Compared to Atypical Antipsychotic Standard of Care in Patients With DSM-IV-TR Schizophrenia
Status: Enrolling
Updated:  9/7/2012
Clinical Research Facility
mi
from
Norfolk, VA
A Long-Term, Open-Label, Study on Schizophrenia
A Long-Term, Open-Label, Multicenter Study of LY2140023 Compared to Atypical Antipsychotic Standard of Care in Patients With DSM-IV-TR Schizophrenia
Status: Enrolling
Updated: 9/7/2012
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
A Long-Term Study in Schizophrenia
Long-Term Open-Label Safety Study of Pomaglumetad Methionil in Patients With Schizophrenia
Status: Enrolling
Updated:  9/7/2012
Clinical Research Facility
mi
from
Los Angeles, CA
A Long-Term Study in Schizophrenia
Long-Term Open-Label Safety Study of Pomaglumetad Methionil in Patients With Schizophrenia
Status: Enrolling
Updated: 9/7/2012
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Long-Term Study in Schizophrenia
Long-Term Open-Label Safety Study of Pomaglumetad Methionil in Patients With Schizophrenia
Status: Enrolling
Updated:  9/7/2012
Clinical Research Facility
mi
from
Washington,
A Long-Term Study in Schizophrenia
Long-Term Open-Label Safety Study of Pomaglumetad Methionil in Patients With Schizophrenia
Status: Enrolling
Updated: 9/7/2012
Clinical Research Facility
mi
from
Washington,
Click here to add this to my saved trials
A Long-Term Study in Schizophrenia
Long-Term Open-Label Safety Study of Pomaglumetad Methionil in Patients With Schizophrenia
Status: Enrolling
Updated:  9/7/2012
Clinical Research Facility
mi
from
Miami, FL
A Long-Term Study in Schizophrenia
Long-Term Open-Label Safety Study of Pomaglumetad Methionil in Patients With Schizophrenia
Status: Enrolling
Updated: 9/7/2012
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Long-Term Study in Schizophrenia
Long-Term Open-Label Safety Study of Pomaglumetad Methionil in Patients With Schizophrenia
Status: Enrolling
Updated:  9/7/2012
Clinical Research Facility
mi
from
Chicago, IL
A Long-Term Study in Schizophrenia
Long-Term Open-Label Safety Study of Pomaglumetad Methionil in Patients With Schizophrenia
Status: Enrolling
Updated: 9/7/2012
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
A Long-Term Study in Schizophrenia
Long-Term Open-Label Safety Study of Pomaglumetad Methionil in Patients With Schizophrenia
Status: Enrolling
Updated:  9/7/2012
Clinical Research Facility
mi
from
Indianapolis, IN
A Long-Term Study in Schizophrenia
Long-Term Open-Label Safety Study of Pomaglumetad Methionil in Patients With Schizophrenia
Status: Enrolling
Updated: 9/7/2012
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Long-Term Study in Schizophrenia
Long-Term Open-Label Safety Study of Pomaglumetad Methionil in Patients With Schizophrenia
Status: Enrolling
Updated:  9/7/2012
Clinical Research Facility
mi
from
Alexandria, LA
A Long-Term Study in Schizophrenia
Long-Term Open-Label Safety Study of Pomaglumetad Methionil in Patients With Schizophrenia
Status: Enrolling
Updated: 9/7/2012
Clinical Research Facility
mi
from
Alexandria, LA
Click here to add this to my saved trials
A Long-Term Study in Schizophrenia
Long-Term Open-Label Safety Study of Pomaglumetad Methionil in Patients With Schizophrenia
Status: Enrolling
Updated:  9/7/2012
Clinical Research Facility
mi
from
Picayune, MS
A Long-Term Study in Schizophrenia
Long-Term Open-Label Safety Study of Pomaglumetad Methionil in Patients With Schizophrenia
Status: Enrolling
Updated: 9/7/2012
Clinical Research Facility
mi
from
Picayune, MS
Click here to add this to my saved trials
A Long-Term Study in Schizophrenia
Long-Term Open-Label Safety Study of Pomaglumetad Methionil in Patients With Schizophrenia
Status: Enrolling
Updated:  9/7/2012
Clinical Research Facility
mi
from
Kansas City, MO
A Long-Term Study in Schizophrenia
Long-Term Open-Label Safety Study of Pomaglumetad Methionil in Patients With Schizophrenia
Status: Enrolling
Updated: 9/7/2012
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
A Long-Term Study in Schizophrenia
Long-Term Open-Label Safety Study of Pomaglumetad Methionil in Patients With Schizophrenia
Status: Enrolling
Updated:  9/7/2012
Clinical Research Facility
mi
from
Bridgewater, NJ
A Long-Term Study in Schizophrenia
Long-Term Open-Label Safety Study of Pomaglumetad Methionil in Patients With Schizophrenia
Status: Enrolling
Updated: 9/7/2012
Clinical Research Facility
mi
from
Bridgewater, NJ
Click here to add this to my saved trials
A Long-Term Study in Schizophrenia
Long-Term Open-Label Safety Study of Pomaglumetad Methionil in Patients With Schizophrenia
Status: Enrolling
Updated:  9/7/2012
Clinical Research Facility
mi
from
Brooklyn, NY
A Long-Term Study in Schizophrenia
Long-Term Open-Label Safety Study of Pomaglumetad Methionil in Patients With Schizophrenia
Status: Enrolling
Updated: 9/7/2012
Clinical Research Facility
mi
from
Brooklyn, NY
Click here to add this to my saved trials
A Long-Term Study in Schizophrenia
Long-Term Open-Label Safety Study of Pomaglumetad Methionil in Patients With Schizophrenia
Status: Enrolling
Updated:  9/7/2012
Clinical Research Facility
mi
from
Chapel Hill, NC
A Long-Term Study in Schizophrenia
Long-Term Open-Label Safety Study of Pomaglumetad Methionil in Patients With Schizophrenia
Status: Enrolling
Updated: 9/7/2012
Clinical Research Facility
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
A Long-Term Study in Schizophrenia
Long-Term Open-Label Safety Study of Pomaglumetad Methionil in Patients With Schizophrenia
Status: Enrolling
Updated:  9/7/2012
Clinical Research Facility
mi
from
Cincinnati, OH
A Long-Term Study in Schizophrenia
Long-Term Open-Label Safety Study of Pomaglumetad Methionil in Patients With Schizophrenia
Status: Enrolling
Updated: 9/7/2012
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Long-Term Study in Schizophrenia
Long-Term Open-Label Safety Study of Pomaglumetad Methionil in Patients With Schizophrenia
Status: Enrolling
Updated:  9/7/2012
Clinical Research Facility
mi
from
Muskogee, OK
A Long-Term Study in Schizophrenia
Long-Term Open-Label Safety Study of Pomaglumetad Methionil in Patients With Schizophrenia
Status: Enrolling
Updated: 9/7/2012
Clinical Research Facility
mi
from
Muskogee, OK
Click here to add this to my saved trials
A Long-Term Study in Schizophrenia
Long-Term Open-Label Safety Study of Pomaglumetad Methionil in Patients With Schizophrenia
Status: Enrolling
Updated:  9/7/2012
Clinical Research Facility
mi
from
Portland, OR
A Long-Term Study in Schizophrenia
Long-Term Open-Label Safety Study of Pomaglumetad Methionil in Patients With Schizophrenia
Status: Enrolling
Updated: 9/7/2012
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
A Long-Term Study in Schizophrenia
Long-Term Open-Label Safety Study of Pomaglumetad Methionil in Patients With Schizophrenia
Status: Enrolling
Updated:  9/7/2012
Clinical Research Facility
mi
from
Philadelphia, PA
A Long-Term Study in Schizophrenia
Long-Term Open-Label Safety Study of Pomaglumetad Methionil in Patients With Schizophrenia
Status: Enrolling
Updated: 9/7/2012
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Long-Term Study in Schizophrenia
Long-Term Open-Label Safety Study of Pomaglumetad Methionil in Patients With Schizophrenia
Status: Enrolling
Updated:  9/7/2012
Clinical Research Facility
mi
from
Fort Worth, TX
A Long-Term Study in Schizophrenia
Long-Term Open-Label Safety Study of Pomaglumetad Methionil in Patients With Schizophrenia
Status: Enrolling
Updated: 9/7/2012
Clinical Research Facility
mi
from
Fort Worth, TX
Click here to add this to my saved trials
A Long-Term Study in Schizophrenia
Long-Term Open-Label Safety Study of Pomaglumetad Methionil in Patients With Schizophrenia
Status: Enrolling
Updated:  9/7/2012
Clinical Research Facility
mi
from
Norfolk, VA
A Long-Term Study in Schizophrenia
Long-Term Open-Label Safety Study of Pomaglumetad Methionil in Patients With Schizophrenia
Status: Enrolling
Updated: 9/7/2012
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
A Long-Term Study in Schizophrenia
Long-Term Open-Label Safety Study of Pomaglumetad Methionil in Patients With Schizophrenia
Status: Enrolling
Updated:  9/7/2012
Clinical Research Facility
mi
from
Seattle, WA
A Long-Term Study in Schizophrenia
Long-Term Open-Label Safety Study of Pomaglumetad Methionil in Patients With Schizophrenia
Status: Enrolling
Updated: 9/7/2012
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
A Fifteen-month, Prospective, Randomized, Active-controlled, Open-label, Flexible Dose Study of Paliperidone Palmitate Compared With Oral Antipsychotic Treatment in Delaying Time to Treatment Failure in Adults With Schizophrenia Who Have Been Incarcerated
Status: Enrolling
Updated:  10/1/2012
Clinical Research Facility
mi
from
Phoenix, AZ
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
A Fifteen-month, Prospective, Randomized, Active-controlled, Open-label, Flexible Dose Study of Paliperidone Palmitate Compared With Oral Antipsychotic Treatment in Delaying Time to Treatment Failure in Adults With Schizophrenia Who Have Been Incarcerated
Status: Enrolling
Updated: 10/1/2012
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
A Fifteen-month, Prospective, Randomized, Active-controlled, Open-label, Flexible Dose Study of Paliperidone Palmitate Compared With Oral Antipsychotic Treatment in Delaying Time to Treatment Failure in Adults With Schizophrenia Who Have Been Incarcerated
Status: Enrolling
Updated:  10/1/2012
Clinical Research Facility
mi
from
Fort Smith, AR
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
A Fifteen-month, Prospective, Randomized, Active-controlled, Open-label, Flexible Dose Study of Paliperidone Palmitate Compared With Oral Antipsychotic Treatment in Delaying Time to Treatment Failure in Adults With Schizophrenia Who Have Been Incarcerated
Status: Enrolling
Updated: 10/1/2012
Clinical Research Facility
mi
from
Fort Smith, AR
Click here to add this to my saved trials
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
A Fifteen-month, Prospective, Randomized, Active-controlled, Open-label, Flexible Dose Study of Paliperidone Palmitate Compared With Oral Antipsychotic Treatment in Delaying Time to Treatment Failure in Adults With Schizophrenia Who Have Been Incarcerated
Status: Enrolling
Updated:  10/1/2012
Clinical Research Facility
mi
from
Santa Clara, CA
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
A Fifteen-month, Prospective, Randomized, Active-controlled, Open-label, Flexible Dose Study of Paliperidone Palmitate Compared With Oral Antipsychotic Treatment in Delaying Time to Treatment Failure in Adults With Schizophrenia Who Have Been Incarcerated
Status: Enrolling
Updated: 10/1/2012
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
A Fifteen-month, Prospective, Randomized, Active-controlled, Open-label, Flexible Dose Study of Paliperidone Palmitate Compared With Oral Antipsychotic Treatment in Delaying Time to Treatment Failure in Adults With Schizophrenia Who Have Been Incarcerated
Status: Enrolling
Updated:  10/1/2012
Clinical Research Facility
mi
from
Bridgeport, CT
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
A Fifteen-month, Prospective, Randomized, Active-controlled, Open-label, Flexible Dose Study of Paliperidone Palmitate Compared With Oral Antipsychotic Treatment in Delaying Time to Treatment Failure in Adults With Schizophrenia Who Have Been Incarcerated
Status: Enrolling
Updated: 10/1/2012
Clinical Research Facility
mi
from
Bridgeport, CT
Click here to add this to my saved trials
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
A Fifteen-month, Prospective, Randomized, Active-controlled, Open-label, Flexible Dose Study of Paliperidone Palmitate Compared With Oral Antipsychotic Treatment in Delaying Time to Treatment Failure in Adults With Schizophrenia Who Have Been Incarcerated
Status: Enrolling
Updated:  10/1/2012
Clinical Research Facility
mi
from
Daytona Beach, FL
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
A Fifteen-month, Prospective, Randomized, Active-controlled, Open-label, Flexible Dose Study of Paliperidone Palmitate Compared With Oral Antipsychotic Treatment in Delaying Time to Treatment Failure in Adults With Schizophrenia Who Have Been Incarcerated
Status: Enrolling
Updated: 10/1/2012
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
A Fifteen-month, Prospective, Randomized, Active-controlled, Open-label, Flexible Dose Study of Paliperidone Palmitate Compared With Oral Antipsychotic Treatment in Delaying Time to Treatment Failure in Adults With Schizophrenia Who Have Been Incarcerated
Status: Enrolling
Updated:  10/1/2012
Clinical Research Facility
mi
from
Decatur, GA
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
A Fifteen-month, Prospective, Randomized, Active-controlled, Open-label, Flexible Dose Study of Paliperidone Palmitate Compared With Oral Antipsychotic Treatment in Delaying Time to Treatment Failure in Adults With Schizophrenia Who Have Been Incarcerated
Status: Enrolling
Updated: 10/1/2012
Clinical Research Facility
mi
from
Decatur, GA
Click here to add this to my saved trials
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
A Fifteen-month, Prospective, Randomized, Active-controlled, Open-label, Flexible Dose Study of Paliperidone Palmitate Compared With Oral Antipsychotic Treatment in Delaying Time to Treatment Failure in Adults With Schizophrenia Who Have Been Incarcerated
Status: Enrolling
Updated:  10/1/2012
Clinical Research Facility
mi
from
Honolulu, HI
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
A Fifteen-month, Prospective, Randomized, Active-controlled, Open-label, Flexible Dose Study of Paliperidone Palmitate Compared With Oral Antipsychotic Treatment in Delaying Time to Treatment Failure in Adults With Schizophrenia Who Have Been Incarcerated
Status: Enrolling
Updated: 10/1/2012
Clinical Research Facility
mi
from
Honolulu, HI
Click here to add this to my saved trials
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
A Fifteen-month, Prospective, Randomized, Active-controlled, Open-label, Flexible Dose Study of Paliperidone Palmitate Compared With Oral Antipsychotic Treatment in Delaying Time to Treatment Failure in Adults With Schizophrenia Who Have Been Incarcerated
Status: Enrolling
Updated:  10/1/2012
Clinical Research Facility
mi
from
Park Ridge, IL
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
A Fifteen-month, Prospective, Randomized, Active-controlled, Open-label, Flexible Dose Study of Paliperidone Palmitate Compared With Oral Antipsychotic Treatment in Delaying Time to Treatment Failure in Adults With Schizophrenia Who Have Been Incarcerated
Status: Enrolling
Updated: 10/1/2012
Clinical Research Facility
mi
from
Park Ridge, IL
Click here to add this to my saved trials
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
A Fifteen-month, Prospective, Randomized, Active-controlled, Open-label, Flexible Dose Study of Paliperidone Palmitate Compared With Oral Antipsychotic Treatment in Delaying Time to Treatment Failure in Adults With Schizophrenia Who Have Been Incarcerated
Status: Enrolling
Updated:  10/1/2012
Clinical Research Facility
mi
from
Bettendorf, IA
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
A Fifteen-month, Prospective, Randomized, Active-controlled, Open-label, Flexible Dose Study of Paliperidone Palmitate Compared With Oral Antipsychotic Treatment in Delaying Time to Treatment Failure in Adults With Schizophrenia Who Have Been Incarcerated
Status: Enrolling
Updated: 10/1/2012
Clinical Research Facility
mi
from
Bettendorf, IA
Click here to add this to my saved trials
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
A Fifteen-month, Prospective, Randomized, Active-controlled, Open-label, Flexible Dose Study of Paliperidone Palmitate Compared With Oral Antipsychotic Treatment in Delaying Time to Treatment Failure in Adults With Schizophrenia Who Have Been Incarcerated
Status: Enrolling
Updated:  10/1/2012
Clinical Research Facility
mi
from
Overland Park, KA
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
A Fifteen-month, Prospective, Randomized, Active-controlled, Open-label, Flexible Dose Study of Paliperidone Palmitate Compared With Oral Antipsychotic Treatment in Delaying Time to Treatment Failure in Adults With Schizophrenia Who Have Been Incarcerated
Status: Enrolling
Updated: 10/1/2012
Clinical Research Facility
mi
from
Overland Park, KA
Click here to add this to my saved trials
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
A Fifteen-month, Prospective, Randomized, Active-controlled, Open-label, Flexible Dose Study of Paliperidone Palmitate Compared With Oral Antipsychotic Treatment in Delaying Time to Treatment Failure in Adults With Schizophrenia Who Have Been Incarcerated
Status: Enrolling
Updated:  10/1/2012
Clinical Research Facility
mi
from
Louisville, KY
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
A Fifteen-month, Prospective, Randomized, Active-controlled, Open-label, Flexible Dose Study of Paliperidone Palmitate Compared With Oral Antipsychotic Treatment in Delaying Time to Treatment Failure in Adults With Schizophrenia Who Have Been Incarcerated
Status: Enrolling
Updated: 10/1/2012
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
A Fifteen-month, Prospective, Randomized, Active-controlled, Open-label, Flexible Dose Study of Paliperidone Palmitate Compared With Oral Antipsychotic Treatment in Delaying Time to Treatment Failure in Adults With Schizophrenia Who Have Been Incarcerated
Status: Enrolling
Updated:  10/1/2012
Clinical Research Facility
mi
from
Metairie, LA
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
A Fifteen-month, Prospective, Randomized, Active-controlled, Open-label, Flexible Dose Study of Paliperidone Palmitate Compared With Oral Antipsychotic Treatment in Delaying Time to Treatment Failure in Adults With Schizophrenia Who Have Been Incarcerated
Status: Enrolling
Updated: 10/1/2012
Clinical Research Facility
mi
from
Metairie, LA
Click here to add this to my saved trials
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
A Fifteen-month, Prospective, Randomized, Active-controlled, Open-label, Flexible Dose Study of Paliperidone Palmitate Compared With Oral Antipsychotic Treatment in Delaying Time to Treatment Failure in Adults With Schizophrenia Who Have Been Incarcerated
Status: Enrolling
Updated:  10/1/2012
Clinical Research Facility
mi
from
Baltimore, MD
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
A Fifteen-month, Prospective, Randomized, Active-controlled, Open-label, Flexible Dose Study of Paliperidone Palmitate Compared With Oral Antipsychotic Treatment in Delaying Time to Treatment Failure in Adults With Schizophrenia Who Have Been Incarcerated
Status: Enrolling
Updated: 10/1/2012
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
A Fifteen-month, Prospective, Randomized, Active-controlled, Open-label, Flexible Dose Study of Paliperidone Palmitate Compared With Oral Antipsychotic Treatment in Delaying Time to Treatment Failure in Adults With Schizophrenia Who Have Been Incarcerated
Status: Enrolling
Updated:  10/1/2012
Clinical Research Facility
mi
from
Boston, MA
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
A Fifteen-month, Prospective, Randomized, Active-controlled, Open-label, Flexible Dose Study of Paliperidone Palmitate Compared With Oral Antipsychotic Treatment in Delaying Time to Treatment Failure in Adults With Schizophrenia Who Have Been Incarcerated
Status: Enrolling
Updated: 10/1/2012
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
A Fifteen-month, Prospective, Randomized, Active-controlled, Open-label, Flexible Dose Study of Paliperidone Palmitate Compared With Oral Antipsychotic Treatment in Delaying Time to Treatment Failure in Adults With Schizophrenia Who Have Been Incarcerated
Status: Enrolling
Updated:  10/1/2012
Clinical Research Facility
mi
from
Ann Arbor, MI
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
A Fifteen-month, Prospective, Randomized, Active-controlled, Open-label, Flexible Dose Study of Paliperidone Palmitate Compared With Oral Antipsychotic Treatment in Delaying Time to Treatment Failure in Adults With Schizophrenia Who Have Been Incarcerated
Status: Enrolling
Updated: 10/1/2012
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials